In a follow-up manuscript, the authors also proved that galactose administration protects pancreatic acinar cells ex vivo and reduces the severity of AP in vivo, suggesting that galactose would be a valuable addition to the current asparaginase treatment protocol [8]. The gene discussed is ASPG; the disease is alkaline phosphatase measurement.